Dual Prescribing Workflow

What the workflow is and why it exists

Dual prescribing workflow is a split prescribing pattern, one path for ordinary prescriptions and another for controlled substances, usually with a paper-based step for the latter. It is not a security control itself, but it creates operational seams that can affect reliability, traceability, and user behaviour.

The core idea is simple: one prescription channel is easier for routine medications, while controlled substances are routed through a more constrained process. That extra friction may be intentional, but it also means the workflow has to bridge two different submission paths, two different sets of exceptions, and two different failure modes.

Where the workflow breaks down

The main failure point is fragmentation. When prescribers must remember which medicines belong in which channel, orders can be delayed, duplicated, or sent to the wrong destination. That can matter operationally even when the clinical intent is correct, because the process asks people to switch context at the point of action.

Another issue is inconsistency. If the two paths are not equally well understood by prescribers, pharmacists, and staff, the workflow can produce incomplete orders, missing signatures, or follow-up calls that slow dispensing. In practice, the risk is less about one isolated mistake and more about small breakdowns accumulating across routine work.

How it affects prescribing behaviour

Dual prescribing can influence choice as well as execution. When the controlled-substance path is harder, some prescribers may prefer pharmacies or operational routes that reduce perceived hassle, even when those choices are not otherwise optimal. The workflow therefore shapes behaviour, not just transaction format.

That makes the process important to measure from the user journey side, not only from a policy perspective. A design that is technically compliant but routinely avoided creates uneven use, workarounds, and avoidable confusion. The practical question is whether the workflow preserves intended controls without creating so much friction that people try to route around it.

Operational controls that make it manageable

Successful use depends on clear channel rules, reliable handoffs, and consistent staff understanding of what belongs where. A workflow like this works best when the system removes ambiguity at the point of prescribing, rather than relying on memory or after-the-fact correction.

It also benefits from governance around exceptions. If paper remains the controlled-substance path, then the organisation needs a clean way to manage exceptions, reconcile missing items, and detect when a prescription was started in the wrong channel. The more split the workflow, the more important it is to keep the process legible for prescribers and staff.

Risk and Threat Considerations

Dual prescribing workflows create process risk because they split a single clinical intent across two channels, which increases the chances of delay, mismatch, or incomplete fulfilment. The more the workflow depends on human recall and manual reconciliation, the more likely errors become under time pressure or volume.

Failure mechanism: Prescribers, pharmacies, or support staff may misroute a prescription, omit a required step, or fail to reconcile the two channels, leading to delayed dispensing or the wrong medication path being used.

Impact: The result can be treatment delay, extra administrative work, patient frustration, and reduced confidence in the prescribing process, especially when the split workflow becomes a routine operational burden.

Practitioner Guidance

What to watch for: The strongest warning sign is not a single error, but recurring exception handling, repeated callback traffic, or prescribers routinely choosing workarounds because the workflow is harder than expected. Those patterns suggest the process is no longer functioning as a clean control boundary.

Governance implication: Own the workflow as a business process, not just a technical route. If one channel is reserved for controlled substances, the organisation should make channel selection obvious, reduce ambiguity at the point of use, and monitor whether the split is creating avoidable friction or unintended prescribing behaviour.

Related resources from NHI Mgmt Group

• Why do electronic prescribing controls need both regulatory oversight and workflow design?
• How should organisations secure workflow platforms that handle both files and secrets?
• Why do workflow engines create such a large blast radius for attackers?
• How should security teams protect NHI secrets stored in AI workflow platforms?